Delivery Order SPE2DB20D3101-SPE2DB24FRDT2

Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $4.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,068.22 delivery order is for the pharmaceutical product Feraheme (ferumoxytol injection) 510 mg/17 mL vial. The contract has a firm fixed price and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $25,193.87, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Feraheme 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of Feraheme (ferumoxytol) 510 mg/17 mL vials to the Defense Logistics Agency (DLA). The $3,913.10 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 23, 2021, with an ultimate completion date of August 24, 2021. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,511.90, is for the delivery of Feraheme 510 mg/17 ml vials and has an ultimate completion date of October 22, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a $11,747.07 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Feraheme, a specialty pharmaceutical product used in the treatment of iron deficiency anemia. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,160.30, is for the delivery of Feraheme 510 mg/17 ml vials, a medication used to treat iron deficiency anemia. The contract is a firm fixed-price delivery order with a completion date of December 24, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,704.28 delivery order is for the pharmaceutical product Feraheme 510 mg/17 ml vial, with an ultimate completion date of September 13, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award is for the delivery of Feraheme, a 510 mg/17 ml vial medication, to the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corp, has a ceiling value of $3,218.17 and was issued as a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc. (doing business as AmerisourceBergen). The IDC, valued up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials, a pharmaceutical product used in the treatment of iron deficiency anemia. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the total ceiling value is $42,742.37. The contract is not set aside for any specific business type. The award is associated with a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,119.99 Firm Fixed Price delivery order is for the supply of Feraheme 510 mg/17 ml vials, a pharmaceutical product used for the treatment of iron deficiency anemia. The award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRDT2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the procurement of Feraheme (ferumoxytol), a 510 mg/17 mL injectable medication, with a ceiling value of $4,516.36 and a period of performance through March 13, 2024.

The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical commodities.

Generated 2/27/25, 12:42 PM